obesity
OBESITY
Obesity is having an excessive amount of body fat that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include addressing the principal cause of weight gain and focusing management on both weight loss and patient-centered health outcomes.
A multidisciplinary approach, that is a combination of dietary change, physical activity and behavioral modification, is recommended.

Obesity Diagnosis

Diagnosis

History

  • Elicit the following in the history: Weight history, eating habits, physical activity, alcohol consumption, smoking, underlying diseases or conditions that hinder physical activities or weight loss, cultural and environmental factors affecting weight
  • Exclude secondary causes of obesity, such as medications (eg Insulin, Nateglinide, Repaglinide, Risperidone, Sertindole, Olanzapine, Clozapine, Mirtazapine, Valproate, Gabapentin), or history of genetic or endocrine disorders (eg hypothyroidism)
  • Detect potential comorbidities [eg type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, sleep apnea, hyperinsulinemia]
    • Its presence may affect the treatment decisions and outcomes
  • Assess mental status (eg patient’s self image, general mental health, stress factors, eating disorder, presence of depression and other mood disorders, substance abuse) and psychosocial barriers
  • Detect pregnancy/lactation in women
    • Not usually recommended for weight loss program
  • Family history (eg obesity, presence of cardiovascular disease, hypertension, DM, dyslipidemia, obesity-related cancer, thyroid disease)

Physical Examination

  • Blood pressure (BP) measurements in both arms
  • Physical exam for evidence of thyroid disease, Cushing’s syndrome, hypogonadism and dysmorphism

Anthropometry

  • Body Mass Index (BMI)
    • Measures relative weight for height
    • Indicates total body fat content
    • Helps predict future health status as raised BMI increases cardiovascular events or deaths, total mortality, DM, sleep disorder, osteoarthritis and certain cancers (eg endometrial, breast, colon, kidney, esophagus)
    • Done annually for screening and as needed for management
    • Calculated by the formula: BMI = weight (kg)/[height (m)]2
      • Asian countries have lower BMI cut-off points for overweight and obesity than the World Health Organization (WHO) BMI values
    • Calculation is for all age groups; BMI percentile for age is used in children <18 years old to determine the healthy weight status 
  • Waist Circumference
    • Useful measurement of intra-abdominal fat content before and during weight loss treatment
    • Technique of choice for classifying central obesity and clinical risk
    • A large waist circumference is associated with an increased risk for DM, dyslipidemia, hypertension and cardiovascular disease in patients who may not be considered obese by conventional BMI criteria

Laboratory Tests

  • To assess comorbidities associated with obesity
    • Lipid profile [eg low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG)]
    • Fasting glucose level, A1C, thyroid function tests
    • Uric acid, liver function (hepatic enzymes), renal function
    • Urine free cortisol levels (perform in patients with signs of Cushing’s syndrome)
    • Lab tests to rule out polycystic ovarian syndrome
    • Electrocardiogram (ECG)
    • Chest X-ray
    • Polysomnography and other sleep studies in patients at high risk for sleep apnea

Assessment

Risk Factor Assessment

Identify absolute risk status based on the presence of the following:

  • Disease Conditions
    • Coronary heart disease (CHD)
    • Atherosclerosis
    • Hypertension
    • Diabetes mellitus
    • Sleep apnea
    • Dyslipidemia
  • Other Obesity-Associated Diseases
    • Gynecological disorders (eg menorrhagia, amenorrhea)
    • Osteoarthritis
    • Asthma
    • Gallstones
    • Stress incontinence
    • Nonalcoholic fatty liver disease
    • Gastroesophageal reflux disease
  • Cardiovascular Risk Factors
    • Cigarette smoking
    • Hypertension
    • Hyperlipidemia
    • Impaired fasting glucose and impaired glucose tolerance
    • Family history of premature CHD [eg myocardial infarction (MI) or sudden death in father/male 1st-degree relative at ≤55 years or mother/female 1st-degree relative at ≤65 years]
    • Age ≥45 years for men or age ≥55 years for women or postmenopausal
  • Others
    • Physical inactivity
    • Elevated serum TG (>2.3 mmol/L) and decreased HDL-C

Classification

ADULT CLASSIFICATION OF WEIGHT BY BODY MASS INDEX
WHO Classification WHO BMI Cut-off Points (kg/m2) Risk of Comorbidities Asian BMI Cut-off Points (kg/m2)
Underweight <18.5 Low but increased risk of other clinical problems <18.5
Normal 18.5-24.9 Average 18.5-22.9
Overweight/Pre-obese 25.0-29.9 Increased 23.0-27.4
Obese Class I 30.0-34.9 Moderate 27.5-32.4
Obese Class II 35.0-39.9 Severe 32.5-37.4
Obese Class III ≥40.0 Very severe ≥37.5
Race High-Risk Waist Circumference (cm)
Men Women
Caucasians ≥102 ≥88
Asians ≥90 ≥80
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
11 May 2020
This second issue revisits the impact EMPA-REG OUTCOME had on clinical practice and helps readers discover how it gives life back to patients through its cardiovascular indication. Learn how it was approved and the possible mechanisms for its cardiovascular benefits.
Stephen Padilla, 22 Jul 2019
Zinc supplementation significantly lowers key glycaemic indicators, particularly fasting glucose (FG) in individuals with diabetes and in those who received an inorganic supplement, results of a systematic review and meta-analysis have shown.
Elaine Soliven, 15 Oct 2020

Higher levels of exercise appear to be associated with a lower risk of all-cause mortality in adults with type 2 diabetes (T2D) compared with no exercise at all, according to a study presented at EASD 2020.